<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">CNS Neurosci Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">CNS Neurosci Ther</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1755-5949</journal-id>
<journal-id journal-id-type="publisher-id">CNS</journal-id>
<journal-title-group>
<journal-title>CNS Neuroscience &amp; Therapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1755-5930</issn>
<issn pub-type="epub">1755-5949</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28695670</article-id>
<article-id pub-id-type="pmc">6492760</article-id>
<article-id pub-id-type="doi">10.1111/cns.12714</article-id>
<article-id pub-id-type="publisher-id">CNS12714</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton <styled-content style="fixed-case">MR</styled-content> spectroscopy and muscle biopsy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="cns12714-cr-0001">
<name>
<surname>Niu</surname>
<given-names>Feng‐Nan</given-names>
</name>
<xref ref-type="aff" rid="cns12714-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12714-cr-0002">
<name>
<surname>Meng</surname>
<given-names>Hai‐Lan</given-names>
</name>
<xref ref-type="aff" rid="cns12714-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12714-cr-0003">
<name>
<surname>Chang</surname>
<given-names>Lei‐Lei</given-names>
</name>
<xref ref-type="aff" rid="cns12714-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12714-cr-0004">
<name>
<surname>Wu</surname>
<given-names>Hong‐Yan</given-names>
</name>
<xref ref-type="aff" rid="cns12714-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12714-cr-0005">
<name>
<surname>Li</surname>
<given-names>Wei‐Ping</given-names>
</name>
<xref ref-type="aff" rid="cns12714-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12714-cr-0006">
<name>
<surname>Liu</surname>
<given-names>Ren‐Yuan</given-names>
</name>
<xref ref-type="aff" rid="cns12714-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12714-cr-0007">
<name>
<surname>Wang</surname>
<given-names>Hui‐Ting</given-names>
</name>
<xref ref-type="aff" rid="cns12714-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="cns12714-cr-0008">
<name>
<surname>Zhang</surname>
<given-names>Bing</given-names>
</name>
<address>
<email>zhangbing_nanjing@vip.163.com</email>
</address>
<xref ref-type="aff" rid="cns12714-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="cns12714-cr-0009">
<name>
<surname>Xu</surname>
<given-names>Yun</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5288-0319</contrib-id>
<address>
<email>xuyun20042001@aliyun.com</email>
</address>
<xref ref-type="aff" rid="cns12714-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="cns12714-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Pathology</named-content>
<named-content content-type="organisation-division">Drum Tower Hospital</named-content>
<institution>Medical School of Nanjing University</institution>
<named-content content-type="city">Nanjing</named-content>
<named-content content-type="country-part">Jiangsu</named-content>
<country country="CN">China</country>
</aff>
<aff id="cns12714-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<named-content content-type="organisation-division">Drum Tower Hospital</named-content>
<institution>Medical School of Nanjing University</institution>
<named-content content-type="city">Nanjing</named-content>
<named-content content-type="country-part">Jiangsu</named-content>
<country country="CN">China</country>
</aff>
<aff id="cns12714-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Radiology</named-content>
<named-content content-type="organisation-division">Drum Tower Hospital</named-content>
<institution>Medical School of Nanjing University</institution>
<named-content content-type="city">Nanjing</named-content>
<named-content content-type="country-part">Jiangsu</named-content>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Yun Xu, Department of Neurology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.<break></break>
Email: <email>xuyun20042001@aliyun.com</email><break></break>
Bing Zhang, Department of Radiology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing , Jiangsu, China.<break></break>
E‐mail address: <email>zhangbing_nanjing@vip.163.com</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>8</month>
<year>2017</year>
</pub-date>
<volume>23</volume>
<issue>8</issue>
<issue-id pub-id-type="doi">10.1111/cns.2017.23.issue-8</issue-id>
<fpage>686</fpage>
<lpage>697</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>3</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>01</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>6</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2017 John Wiley & Sons Ltd <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 John Wiley &amp; Sons Ltd</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:CNS-23-686.pdf" xlink:type="simple"></self-uri>
<abstract id="cns12714-abs-0001">
<title>Summary</title>
<sec id="cns12714-sec-0001">
<title>Aims</title>
<p>Accumulated evidence indicates that cerebral metabolic features, evaluated by proton magnetic resonance spectroscopy (<sup>1</sup>H‐<styled-content style="fixed-case">MRS</styled-content>), are sensitive to early mitochondrion dysfunction associated with mitochondrial encephalomyopathy (<styled-content style="fixed-case">ME</styled-content>). The metabolite ratios of lactate (lac)/Cr, N‐acetyl aspartate (<styled-content style="fixed-case">NAA</styled-content>)/creatine (Cr), total choline (<styled-content style="fixed-case">tC</styled-content>ho)/Cr, and myoinositol (<styled-content style="fixed-case">mI</styled-content>)/Cr are measured in the infarct‐like lesions by <sup>1</sup>H‐<styled-content style="fixed-case">MRS</styled-content> and may reveal metabolic changes associated with <styled-content style="fixed-case">ME</styled-content>. However, the application of this molecular imaging technique in the investigation of the pathology of <styled-content style="fixed-case">ME</styled-content> subtypes is unknown.</p>
</sec>
<sec id="cns12714-sec-0002">
<title>Methods</title>
<p>In this study, cerebral metabolic features of pathologically diagnosed <styled-content style="fixed-case">ME</styled-content> cases, that is, 19 mitochondrial encephalomyopathy, lactic acidosis, and stroke‐like episodes (<styled-content style="fixed-case">MELAS</styled-content>); nine chronic progressive external ophthalmoplegia (<styled-content style="fixed-case">CPEO</styled-content>); and 23 healthy controls, were investigated using <sup>1</sup>H‐<styled-content style="fixed-case">MRS</styled-content>. Receiver operating characteristics (<styled-content style="fixed-case">ROC</styled-content>) analysis was used to evaluate the diagnostic power of the cerebral metabolites. Histochemical evaluation was carried out on muscle tissues derived from biopsy to assess the abnormal mitochondrial proliferation. The association between cerebral metabolic and mitochondrial cytopathy was examined by correlation analysis.</p>
</sec>
<sec id="cns12714-sec-0003">
<title>Results</title>
<p>Patients with <styled-content style="fixed-case">MELAS</styled-content> or <styled-content style="fixed-case">CPEO</styled-content> exhibited a significantly higher Lac/Cr ratio and a lower <styled-content style="fixed-case">NAA</styled-content>/Cr ratio compared with controls. The <styled-content style="fixed-case">ROC</styled-content> curve of Lac/Cr ratio indicated prominent discrimination between <styled-content style="fixed-case">MELAS</styled-content> or <styled-content style="fixed-case">CPEO</styled-content> and healthy control subjects, whereas the <styled-content style="fixed-case">NAA</styled-content>/Cr ratio may present diagnostic power in the distinction of <styled-content style="fixed-case">MELAS</styled-content> from <styled-content style="fixed-case">CPEO</styled-content>. Lower <styled-content style="fixed-case">NAA</styled-content>/Cr ratio was associated with higher Lac/Cr in <styled-content style="fixed-case">MELAS</styled-content>, but not in <styled-content style="fixed-case">CPEO</styled-content>. Furthermore, higher ragged‐red fibers (<styled-content style="fixed-case">RRF</styled-content>s) percentages were associated with elevated Lac/Cr and reduced <styled-content style="fixed-case">NAA</styled-content>/Cr ratios, notably in <styled-content style="fixed-case">MELAS</styled-content>. This association was not noted in the case of <styled-content style="fixed-case">mI</styled-content>/Cr ratio.</p>
</sec>
<sec id="cns12714-sec-0004">
<title>Conclusions</title>
<p>Mitochondrial cytopathy (lactic acidosis and <styled-content style="fixed-case">RRF</styled-content>s on muscle biopsy) was associated with neuronal viability but not glial proliferation, notably in <styled-content style="fixed-case">MELAS</styled-content>. Mitochondrial neuronopathy and neuronal vulnerability are considered significant causes in the pathogenesis of <styled-content style="fixed-case">MELAS</styled-content>, particularly with regard to stroke‐like episodes.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="cns12714-kwd-0001"><sup>1</sup>H‐<styled-content style="fixed-case">MRS</styled-content></kwd>
<kwd id="cns12714-kwd-0002">cerebral metabolic abnormalities</kwd>
<kwd id="cns12714-kwd-0003">
<styled-content style="fixed-case">CPEO</styled-content>
</kwd>
<kwd id="cns12714-kwd-0004">MELAS</kwd>
<kwd id="cns12714-kwd-0005">mitochondrial cytopathy</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Natural Science Foundation of China</funding-source>
<award-id>81671113</award-id>
<award-id>81300977</award-id>
<award-id>81571040</award-id>
<award-id>81230026</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="6"></fig-count>
<table-count count="2"></table-count>
<page-count count="12"></page-count>
<word-count count="7520"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>cns12714</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>August 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.2.1 mode:remove_FC converted:02.05.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="cns12714-cit-1001" publication-type="journal">
<string-name>
<surname>Niu</surname>
<given-names>F‐N</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>H‐L</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>L‐L</given-names>
</string-name>, et al. <article-title>Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy</article-title>. <source xml:lang="en"/>CNS Neurosci Ther. <year>2017</year>;<volume>23</volume>:<fpage>686</fpage>–<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12714</pub-id>
<pub-id pub-id-type="pmid">28695670</pub-id></mixed-citation>
</p>
</notes>
</front>
</article>
</pmc-articleset>